Funding Details
- Awarder
- Inbox
- Date Award
- April 23, 2020
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
-
$120,000,000
Company Info
- Traction
- The lead pneumococcal vaccine includes 24 serotypes and is currently in Phase 2 clinical trials.
- Organizations Involved
- Astellas Pharma
- Company Description
- Affinivax is a biopharmaceutical company developing vaccines that target infectious diseases.
- Market
- Vaccines and Immunotherapies
- Location
-
Cambridge,
MA,
USA
- Coinvestors
- Bain Capital Life Sciences, Viking Global Investors, Ziff Capital Partners, Bill & Melinda Gates Foundation
Links